Adaptive immune response against hepatitis C virus
Abstract: A functional adaptive immune response is the major determinant for clearance of hepatitis C virus (HCV) infection. However, in the majority of patients, this response fails and persistent infection evolves. Here, we dissect the HCV-specific key players of adaptive immunity, namely B cells and T cells, and describe factors that affect infection outcome. Once chronic infection is established, continuous exposure to HCV antigens affects functionality, phenotype, transcriptional program, metabolism, and the epigenetics of the adaptive immune cells. In addition, viral escape mutations contribute to the failure of adaptive antiviral immunity. Direct-acting antivirals (DAA) can mediate HCV clearance in almost all patients with chronic HCV infection, however, defects in adaptive immune cell populations remain, only limited functional memory is obtained and reinfection of cured individuals is possible. Thus, to avoid potential reinfection and achieve global elimination of HCV infections, a prophylactic vaccine is needed. Recent vaccine trials could induce HCV-specific immunity but failed to protect from persistent infection. Thus, lessons from natural protection from persistent infection, DAA-mediated cure, and non-protective vaccination trials might lead the way to successful vaccination strategies in the future
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
International journal of molecular sciences. - 21, 16 (2020) , 5644, ISSN: 1422-0067
- Keyword
-
Hepatitis-C-Virus
T-Lymphozyt
B-Zelle
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2020
- DOI
-
10.3390/ijms21165644
- URN
-
urn:nbn:de:bsz:25-freidok-1668643
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kemming, Janine
- Thimme, Robert
- Neumann-Haefelin, Christoph
- Universität
Time of origin
- 2020
Other Objects (12)
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Chronische Hepatitis-B-Virusinfektion: aktuelle und zukünftige Therapieansätze : = Chronic hepatitis B virus infection: current and future treatment strategies
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Hepatitis B vaccine and NK cells: a new player in memory
Success and failure of virus-specific T Cell responses in Hepatitis C virus infection
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Zytokinmuster im Plasma von Patienten mit chronisch viraler Hepatitis
The role of natural killer cells and CD8+ T cells in hepatitis b virus infection
Heterogeneity of HBV-specific CD8+ T cells and CD56 dim NK cells and their impact on immune failure in chronic HBV infection
Der transjuguläre intrahepatische portosystemische Shunt (TIPS) in der Therapie der portalen Hypertension: Indikation, Stentauswahl, Langzeitverlauf, Komplikationen und prognostische Faktoren in einer retrospektiven monozentrischen Studie
CD8-T-Zell-Differenzierung bei Patienten mit Common Variable Immunodeficiency
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Chronische Hepatitis-B-Virusinfektion: aktuelle und zukünftige Therapieansätze : = Chronic hepatitis B virus infection: current and future treatment strategies
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Hepatitis B vaccine and NK cells: a new player in memory
Success and failure of virus-specific T Cell responses in Hepatitis C virus infection
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Zytokinmuster im Plasma von Patienten mit chronisch viraler Hepatitis
The role of natural killer cells and CD8+ T cells in hepatitis b virus infection
Heterogeneity of HBV-specific CD8+ T cells and CD56 dim NK cells and their impact on immune failure in chronic HBV infection
Der transjuguläre intrahepatische portosystemische Shunt (TIPS) in der Therapie der portalen Hypertension: Indikation, Stentauswahl, Langzeitverlauf, Komplikationen und prognostische Faktoren in einer retrospektiven monozentrischen Studie
CD8-T-Zell-Differenzierung bei Patienten mit Common Variable Immunodeficiency
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Chronische Hepatitis-B-Virusinfektion: aktuelle und zukünftige Therapieansätze : = Chronic hepatitis B virus infection: current and future treatment strategies
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Hepatitis B vaccine and NK cells: a new player in memory
Success and failure of virus-specific T Cell responses in Hepatitis C virus infection
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Zytokinmuster im Plasma von Patienten mit chronisch viraler Hepatitis
The role of natural killer cells and CD8+ T cells in hepatitis b virus infection
Heterogeneity of HBV-specific CD8+ T cells and CD56 dim NK cells and their impact on immune failure in chronic HBV infection
Der transjuguläre intrahepatische portosystemische Shunt (TIPS) in der Therapie der portalen Hypertension: Indikation, Stentauswahl, Langzeitverlauf, Komplikationen und prognostische Faktoren in einer retrospektiven monozentrischen Studie